UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 15, 2016
Accession Number:
0001628280-16-018872
Submission Type:
POS AM
CIK:
0000822411
Company Name:
ImmunoCellular Therapeutics, Ltd.
File Number:
333-211763